tradingkey.logo
tradingkey.logo
Search

CeriBell Inc

CBLL
Add to Watchlist
19.550USD
-0.450-2.25%
Close 07/02, 13:00ETQuotes delayed by 15 min
740.16MMarket Cap
LossP/E TTM

CeriBell Inc

19.550
-0.450-2.25%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.25%

5 Days

-0.91%

1 Month

+11.71%

6 Months

-8.22%

Year to Date

-10.85%

1 Year

+4.94%

Key Figures
20.270Open
20.455High
721.37KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.91%Turnover Ratio
20.000Prev. Close
19.500Low
11.50MTurnover
LossP/E Static
5.26P/B
0.00%Div Yield TTM
-30.84%ROA
24.33052wk High
2.50Volume Ratio
-40.45MNet Profit
37.86MShares
-1.6296EPS TTM
--Beta
-37.53%ROE
10.85052wk Low
4.78%Amplitude
87.27%Gross Margin
740.16MMarket Cap
5.00Reward/Risk
3.29%Risk Rate

TradingKey Stock Score of CeriBell Inc

Currency: USD Updated: 2026-07-02

Key Insights

CeriBell Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 46 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 26.86.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CeriBell Inc's Score

Industry at a Glance

Industry Ranking
46 / 204
Overall Ranking
125 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

CeriBell Inc Highlights

StrengthsRisks
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 96.93% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 89.06M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 89.06M.
Fairly Valued
The company’s latest PE is -12.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 31.90M shares, decreasing 4.88% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 505.35K shares of this stock.

Analyst Rating

Based on 8 analysts
Strong Buy
Current Rating
26.857
Target Price
+34.55%
Upside Space

CeriBell Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

CeriBell Inc Info

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Ticker SymbolCBLL
CompanyCeriBell Inc
CEOChao (Xingjuan)
Websitehttps://ceribell.com/

FAQs

What is the current price of CeriBell Inc (CBLL)?

The current price of CeriBell Inc (CBLL) is 19.55.

What is the symbol of CeriBell Inc?

The ticker symbol of CeriBell Inc is CBLL.

What is the 52-week high of CeriBell Inc?

The 52-week high of CeriBell Inc is 24.33.

What is the 52-week low of CeriBell Inc?

The 52-week low of CeriBell Inc is 10.85.

What is the market capitalization of CeriBell Inc?

The market capitalization of CeriBell Inc is 740.16M.

Is CeriBell Inc (CBLL) currently rated as Buy, Hold, or Sell?

According to analysts, CeriBell Inc (CBLL) has an overall rating of STRONG BUY, with a price target of 26.86.

What is the Earnings Per Share (EPS TTM) of CeriBell Inc (CBLL)?

The Earnings Per Share (EPS TTM) of CeriBell Inc (CBLL) is -1.46.